Telesis Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-49.02	-48.47	-38.96	-18.01	-8.3
Depreciation & Amortization	4.1	2.88	1.57	1.46	0.86
Share-Based Compensation	3.96	3.73	1.09	0.04	0.01
Other Operating Activities	4.99	3.15	-0.4	1.13	1.04
Operating Cash Flow	-34.67	-38.72	-36.7	-15.38	-6.39
Capital Expenditures	-1.96	-4.47	-1.85	-0.2	-0.08
Acquisitions	0	-0.56	-13.19	0	0
Change in Investments	-3.78	-12.98	0	0	0
Investing Cash Flow	-5.74	-18.01	-15.04	-0.2	-0.08
Share Issuance / Repurchase	0.24	0.58	112.66	0.01	0
Debt Issued / Paid	-15.09	3.93	8.65	-0.11	2.72
Other Financing Activities	26.42	-	-0.23	-	32.39
Financing Cash Flow	11.57	4.51	121.08	-0.1	35.11
Exchange Rate Effect	-0	0	0	0	0
Net Cash Flow	-28.85	-52.21	69.34	-15.68	28.64
Free Cash Flow	-36.63	-43.18	-38.55	-15.59	-6.47
Free Cash Flow Margin	-133.16%	-157.40%	-349.11%	-237.00%	-134.63%
Free Cash Flow Per Share	-1.23	-1.47	-2.12	-3.12	-0.43

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).